Coulter-Drexel Translational Research Partnership Program
Over the past five years, Drexel’s Coulter Translational Research Partnership Program has invested more than $5 million in translational research aimed at advancing Drexel’s biomedical technologies toward commercialization, and established a systematic process for project selection and monitoring, which is guided by the Coulter Program Director’s office and the team of advisors consisting of investors and industry and regional economic development agencies’ representatives. This program was originated and sponsored by the Wallace H. Coulter Foundation. In recognition of our accomplishments, in April of 2011, the program was endowed with $10M from the Coulter Foundation, with an equal match from Drexel University, to support our program in perpetuity.
Life Saving Solutions
The global community of biomedical innovators is broad and extremely diverse, yet all of these innovators share a core characteristic: They do not see problems, but instead solutions and opportunities to translate amazing science into lives saved and health improved. To realize these life-saving solutions, these innovators believe that collaboration leads to progress for everyone.